News
With Social Security trust funds estimated to run out in less than a decade, some Americans wonder if Congress will step in ...
Shares of Summit Therapeutics jumped 9% Thursday on a report that it was discussing a lucrative partnership deal with AstraZeneca.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback